Stock·NYSE·Consumer Cyclical
Kohl's Corporation (KSS)
- Market cap
- $2.70B
- P/E
- 10.21
- Dividend yield
- 2.10%
- Street target
- $17.50median of 13 analysts
- 52-week range
- $11.38 $25.22
KSS stock forecast today
Where KSS stands today, and what CleaRank Financial AI makes of it.
KSS at a glance
Kohl's Corporation (KSS): Buy, 70/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($19.18 and $16.91).
- Earnings KSS beat estimates in 7 of its last 8 quarters, yet fell the next day after 4 of those beats.
- Insiders Insiders sold $2.5M and made no open-market purchases over the last 18 months.
- Valuation P/E of 10.2 against 20.8 for the Consumer Cyclical sector: a discount to peers (-51%).
Figures as of October 27, 2026.
CleaRank Financial AI
KSS, or Kohl's Corporation, earns a CleaRank rating of Buy with a model score of 70/100.
Trend contributes the most to that score: the price is 40.62% above its 200-day average and 23.99% above its 50-day average, and the 50-day average is 13.41% above the 200-day. Revenue growth pulls the score down the most, as revenue fell 0.90%, 8.1 percentage points slower than the sector median. The 50-day average is $19.18 and the 200-day is $16.91, and over the past year the price rose 45.27%.
Only on CleaRank
Figures we compute ourselves from KSS's own price, earnings and insider-filing history. Tap one to see it in context.
KSS stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $23.78 is 24.0% above the 50-day simple moving average of $19.18.Price above its 200-day average ›
The price is 40.6% above the 200-day simple moving average of $16.91.50-day average above the 200-day ›
The 50-day average ($19.18) is 13.4% above the 200-day average ($16.91), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 90% of its 52-week range, between $11.38 and $25.22.
KSS share price
Pick a period: each tab shows how far KSS has moved over it, to the last close.
Today's trading
Where KSS sits inside today's range and its 52-week range.
KSS fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 10.21 is 50.9% below the Consumer Cyclical median of 20.8.P/S below the sector median ›
The price-to-sales ratio of 0.17 is 90.8% below the sector median of 1.9.Profitable over the last 12 months ›
Net income over the last 12 months was $270.0M on revenue of $15.4B, a net margin of 1.7%.Beat estimates in most recent reports ›
KSS beat the EPS estimate in 7 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 2.10%, or $0.5 a share a year.
Key statistics
The headline figures for KSS.
As of October 27, 2026, KSS trades at $23.78, with a market value of $2.70B, a P/E ratio of 10.21 and a dividend yield of 2.10%.
What the numbers say
CleaRank Financial AI's reading of KSS's valuation, growth and risks.
Against a Consumer Cyclical median trailing P/E of 20.8, KSS trades on 10.21, which is 50.9% below that median. The peer comparison on this page rates that as a discount to peers. KSS's P/S of 0.17 is 91.1% below the sector median P/S of 1.9. The company carries a market value of $2.7B, and its trailing earnings are $2.33 a share.
Revenue fell 0.90% in the latest quarter compared with the same quarter a year earlier, which left it 8.1 percentage points slower than the sector median of 7.2%. On profitability, the net margin is 1.75% and the operating margin is 4.58%. Return on equity comes in at 6.67%, below the sector median of 12.4%. Debt-to-equity is 1.54, and the trailing dividend yield is 2.10%, or $0.50 a share per year.
The stock rose 7.49% after the November 25, 2025 report, which beat the estimate by 162.50%. For this fiscal year analysts expect EPS of $2.14, a growth rate of 32.1%, and $1.56 for next year.
KSS typically moves about 3.34% a day. Its beta against the S&P 500 is 1.35.
KSS against the Consumer Cyclical sector
How KSS compares with the median Consumer Cyclical stock CleaRank tracks.
Price to earnings vs sector: KSS trades at a notable discount to sector peers (-51%), which may indicate undervaluation or specific company headwinds.
Return vs SPY: Since May 15, 2025, KSS has gained 184.1% against a gain of 30.4% for SPY.
Performance against SPY
KSS and the S&P 500 (SPY) over the same days.
Revenue and earnings
How much KSS sells, and how much of it becomes profit.
Revenue growth: Revenue fell 4.3% in FY2026 to $15.5B, from $16.2B a year earlier.
Profit margin: The net margin was 1.8% in FY2026, up from 0.7% the year before.
Profitable: KSS earned $272M in FY2026.
Earnings reality check
Did KSS beat what analysts expected, and how did the stock react?
Earnings record: KSS beat the analyst estimate in 7 of the last 8 quarters.
Market reaction: The stock fell in the first session after 4 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 26, 2026after close | $0.57 | $1.28 | +124.56% | +1.17% | +7.08% |
| May 28, 2026after close | -$0.19 | -$0.13 | +31.58% | -7.89% | +2.37% |
| Mar 10, 2026after close | $0.84 | $1.07 | +27.38% | -5.42% | -12.96% |
| Nov 25, 2025after close | -$0.16 | $0.10 | +162.50% | +7.49% | +2.45% |
| Aug 27, 2025after close | $0.30 | $0.56 | +86.67% | -4.95% | +1.55% |
| May 29, 2025after close | -$0.22 | -$0.13 | +40.91% | +1.12% | +6.59% |
| Mar 11, 2025after close | $0.74 | $0.95 | +28.38% | -5.90% | -8.96% |
| Nov 26, 2024after close | $0.28 | $0.20 | -28.57% | -3.09% | +0.53% |
As of October 27, 2026, KSS has beaten the analyst EPS estimate in 7 of its last 8 reported quarters and fell in the first trading session after 4 of those beats; its latest report, on August 26, 2026, came in 124.56% above the estimate and the stock moved +1.17% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
KSS AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 69.0, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 69.0 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of KSS
The score, the reasoning behind it, and what could move the price next.
The trend is up for KSS. Its price of $23.78 sits 40.62% above the 200-day average of $16.91 and 23.99% above the 50-day average of $19.18. The price is at 90% of its 52-week range, which leaves it 5.71% below the 52-week high of $25.22.
On momentum, the 14-day RSI reads 69.0, in the bullish zone, below the overbought line, with the MACD line positive. The recent returns all show a gain, with the price up 24.57% over the past three months, 60.57% over the past six months and 45.27% over the past year.
Analyst upgrade ›
Gordon Haskett upgraded it to Buy from Hold on October 22, 2026.
Source: Analyst action, Gordon Haskett, October 22, 2026
New analyst coverage ›
Morgan Stanley restarted coverage at Underweight on July 6, 2026.
Source: Analyst action, Morgan Stanley, July 6, 2026
- The two levels to track are the 52-week high at $25.22, which sits above the price, and the 20-day EMA at $21.61, which sits below it.
- Momentum is bullish, with the 14-day RSI at 69.0 in the bullish zone and the MACD line positive. Readings above 70 or below 30 would signal stretched momentum.
KSS is above its 50-day and 200-day moving averages ($19.18 and $16.91), and that keeps the trend up. A drop through the 50-day average would be the first warning sign. The closest level beneath the price is the 20-day EMA, at $21.61.
KSS has the 52-week high of $25.22 as its next level overhead. Its RSI is in the bullish band, supporting the current direction while sitting near the overbought line.
Technical indicators
Momentum and trend for KSS, from its daily closes.
As of October 27, 2026, with KSS at $23.78, its 14-day RSI is 69.0 (showing bullish momentum without being overbought), its 50-day simple moving average is $19.18 and its 200-day is $16.91.
Calculated by CleaRank on daily closes as of October 27, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What KSS moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 27, 2026, KSS's 1-year correlation of daily returns is +0.35 with S&P 500 (SPY), +0.30 with Nasdaq 100 (QQQ), +0.13 with Bitcoin (BTC) and +0.00 with gold (XAU).
KSS price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
2 of 13 analysts rate it a buy or strong buy, 6 a hold and 5 a sell.Median target above the price ›
The median 12-month target of $17.50 is 26.4% below the price.More buy ratings than three months ago ›
2 of 13 rate it a buy now, against 2 of 14 three months ago.
KSS Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 22, 2026 | Gordon Haskett | Upgrade | Buy |
| Sep 18, 2026 | BTIG | Reiterates | Neutral |
| Aug 27, 2026 | Baird | Maintains | Neutral |
| Aug 18, 2026 | JP Morgan | Maintains | Underweight |
| Jul 6, 2026 | Morgan Stanley | Reinstates | Underweight |
| Jun 8, 2026 | TD Cowen | Maintains | Hold |
As of October 27, 2026, 13 Wall Street analysts cover KSS: 2 rate it a buy or strong buy, 6 a hold and 5 a sell or strong sell. Their 12-month price targets range from $9.00 to $41.50. The median KSS price target is $17.50, 26.4% below the price of $23.78.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
KSS trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
KSS trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
KSS moves about 3.3% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much KSS tends to move, against the market and on its own.
KSS price history and drawdowns
KSS's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 3.34% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 88.1%, from September 2018 to April 2025; the price is still 55.8% below that peak.Most 1-year holds ended higher ›
46% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $8,923, against $42,015 in the S&P 500 (SPY).
KSS Drawdowns & Recovery
As of October 27, 2026, KSS's worst peak-to-trough fall over the last 10 years with dividends reinvested was -88.1% (September 2018 to April 2025); it is still 55.8% below that peak, and 46% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into KSS in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: KSS trailed the S&P 500 over this period: $8,922.66 against $42,015.
A $10,000 investment in KSS in October 2016 would be worth about $8,923 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to KSS, and which have not.
Strongest month, December: an average of +6.26%, up in 5 of 10 years.
Weakest month, March: an average of -10.90%, up in 5 of 10 years.
This month, October: has averaged +4.05%, up in 6 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, KSS's strongest calendar month has been December (average +6.26%, up in 5 of 10 years) and its weakest March (average -10.90%, up in 5 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
KSS stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in KSS, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in KSS today could grow to about $9,847 by 2030 in the base case, with a 90th-percentile outcome near $35,474 and a 10th-percentile outcome around $2,734. The simulation models price only; at today's 2.10% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
KSS Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $23.42 for KSS by 2030 in the base case, from $23.78 today (1.0x over 4 years). The 10th-percentile path ends near $6.50. These are outcomes of a Monte Carlo simulation run on KSS's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $12.48 | $23.69 | $44.96 | |
| 2028 | $9.53 | $23.60 | $58.40 | |
| 2029 | $7.75 | $23.51 | $71.32 | |
| 2030 | $6.50 | $23.42 | $84.36 |
Method: a lognormal simulation of KSS's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
KSS insider trading
What the people running the company have bought and sold.
KSS insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought KSS shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 27, 2026, KSS insiders reported 13 open-market sales worth $2.5M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 15, 2026 | Jennifer J Kent
Officer
|
Sell | 22.9K | $504.7K |
| Oct 15, 2026 | Arianne Parisi
Officer
|
Grant | 8.0K | - |
| Oct 15, 2026 | Elliott Rodgers
Chief Operating Officer
|
Grant | 33.5K | - |
| Oct 15, 2026 | Ryan M Waymire
Officer
|
Grant | 165.1K | - |
| Sep 23, 2026 | Wendy C Arlin
Director
|
Grant | 423 | - |
| Sep 23, 2026 | Niren Chaudhary
Director
|
Grant | 55 | - |
| Sep 23, 2026 | Yael Cosset
Director
|
Grant | 158 | - |
| Sep 23, 2026 | H Charles Floyd
Director
|
Grant | 225 | - |
| Sep 23, 2026 | Robbin Mitchell
Director
|
Grant | 273 | - |
| Sep 23, 2026 | Jonas Prising
Director
|
Grant | 103 | - |
| Sep 23, 2026 | Adolfo Villagomez
Director
|
Grant | 99 | - |
| Sep 15, 2026 | Steven E. Dee
Chief Technology Officer
|
Grant | 139 | - |
| Aug 14, 2026 | Wendy C Arlin
Director
|
Grant | 8.9K | - |
| Aug 14, 2026 | Niren Chaudhary
Director
|
Grant | 7.5K | - |
| Aug 14, 2026 | Adolfo Villagomez
Director
|
Grant | 1.6K | - |
| Aug 3, 2026 | Jennifer J Kent
Officer
|
Sell | 22.9K | $458.8K |
| Aug 3, 2026 | Christie Raymond
Officer
|
Sell | 15.0K | $300.0K |
| Jul 16, 2026 | Marissa A. Steinmetz
Officer
|
Sell | 53 | $910 |
| Jul 15, 2026 | Marissa A. Steinmetz
Officer
|
Grant | 107 | - |
| Jun 24, 2026 | Wendy C Arlin
Director
|
Grant | 320 | - |
| Jun 24, 2026 | Yael Cosset
Director
|
Grant | 140 | - |
| Jun 24, 2026 | H Charles Floyd
Director
|
Grant | 201 | - |
| Jun 24, 2026 | Robbin Mitchell
Director
|
Grant | 243 | - |
| Jun 24, 2026 | Jonas Prising
Director
|
Grant | 92 | - |
| Jun 24, 2026 | Christie Raymond
Officer
|
Grant | 84 | - |
| Jun 24, 2026 | John E Schlifske
Director
|
Grant | 187 | - |
| Jun 24, 2026 | Adolfo Villagomez
Director
|
Grant | 78 | - |
| Jun 15, 2026 | Christie Raymond
Officer
|
Grant | 2.2K | - |
| May 20, 2026 | Wendy C Arlin
Director
|
Grant | 16.4K | - |
| May 20, 2026 | Yael Cosset
Director
|
Grant | 13.5K | - |
| May 20, 2026 | H Charles Floyd
Director
|
Grant | 11.9K | - |
| May 20, 2026 | Robbin Mitchell
Director
|
Grant | 11.9K | - |
| May 20, 2026 | Jonas Prising
Director
|
Grant | 13.9K | - |
| May 20, 2026 | John E Schlifske
Director
|
Grant | 28.3K | - |
| May 20, 2026 | Adolfo Villagomez
Director
|
Grant | 11.9K | - |
| May 15, 2026 | Michael J Bender
Chief Executive Officer
|
Grant | 17.1K | - |
| Apr 15, 2026 | Marissa A. Steinmetz
Officer
|
Sell | 351 | $4.7K |
| Apr 14, 2026 | Marissa A. Steinmetz
Officer
|
Grant | 513 | - |
| Apr 6, 2026 | Marissa A. Steinmetz
Officer
|
Sell | 112 | $1.5K |
| Apr 1, 2026 | Marissa Steinmetz
Officer
|
Sell | 2.0K | $25.4K |
| Apr 1, 2026 | Wendy C Arlin
Director
|
Grant | 308 | - |
| Apr 1, 2026 | Yael Cosset
Director
|
Grant | 278 | - |
| Apr 1, 2026 | H Charles Floyd
Director
|
Grant | 178 | - |
| Apr 1, 2026 | Fred Hand
Officer
|
Grant | 526 | - |
| Apr 1, 2026 | Nicholas David George Jones
Officer
|
Grant | 866 | - |
| Apr 1, 2026 | Jennifer J Kent
Officer
|
Grant | 582 | - |
| Apr 1, 2026 | Robbin Mitchell
Director
|
Grant | 240 | - |
| Apr 1, 2026 | Jonas Prising
Director
|
Grant | 209 | - |
| Apr 1, 2026 | Christie Raymond
Officer
|
Grant | 588 | - |
| Apr 1, 2026 | John E Schlifske
Director
|
Grant | 425 | - |
| Apr 1, 2026 | Marissa Steinmetz
Officer
|
Grant | 266 | - |
| Apr 1, 2026 | Jill Timm
Chief Financial Officer
|
Grant | 919 | - |
| Apr 1, 2026 | Adolfo Villagomez
Director
|
Grant | 178 | - |
| Mar 31, 2026 | Fred Hand
Officer
|
Grant | 937 | - |
| Mar 31, 2026 | Nicholas David George Jones
Officer
|
Grant | 76.5K | - |
| Mar 31, 2026 | Jennifer J Kent
Officer
|
Grant | 58.1K | - |
| Mar 31, 2026 | Christie Raymond
Officer
|
Grant | 49.9K | - |
| Mar 31, 2026 | Marissa Steinmetz
Officer
|
Grant | 33.1K | - |
| Mar 31, 2026 | Jill Timm
Chief Financial Officer
|
Grant | 92.9K | - |
| Mar 30, 2026 | Marissa Steinmetz
Officer
|
Sell | 606 | $7.5K |
| Mar 30, 2026 | Michael J Bender
Chief Executive Officer
|
Grant | 311.5K | - |
| Mar 30, 2026 | Steven E. Dee
Chief Technology Officer
|
Grant | 49.2K | - |
| Mar 27, 2026 | Nicholas David George Jones
Officer
|
Grant | 2.1K | - |
| Mar 27, 2026 | Jennifer J Kent
Officer
|
Grant | 1.4K | - |
| Mar 27, 2026 | Christie Raymond
Officer
|
Grant | 341 | - |
| Mar 27, 2026 | Christie Raymond
Officer
|
Grant | 1.4K | - |
| Mar 27, 2026 | Marissa Steinmetz
Officer
|
Grant | 662 | - |
| Mar 27, 2026 | Marissa Steinmetz
Officer
|
Grant | 157 | - |
| Mar 27, 2026 | Jill Timm
Chief Financial Officer
|
Grant | 814 | - |
| Mar 27, 2026 | Jill Timm
Chief Financial Officer
|
Grant | 2.2K | - |
| Mar 26, 2026 | Marissa Steinmetz
Officer
|
Sell | 457 | $5.7K |
| Mar 25, 2026 | Fred Hand
Officer
|
Grant | 990 | - |
| Mar 25, 2026 | Nicholas David George Jones
Officer
|
Grant | 997 | - |
| Mar 25, 2026 | Jennifer J Kent
Officer
|
Grant | 743 | - |
| Mar 25, 2026 | Christie Raymond
Officer
|
Grant | 650 | - |
| Mar 25, 2026 | Marissa Steinmetz
Officer
|
Grant | 312 | - |
| Mar 25, 2026 | Jill Timm
Chief Financial Officer
|
Grant | 997 | - |
| Mar 20, 2026 | Marissa Steinmetz
Officer
|
Sell | 1.6K | $20.3K |
| Mar 19, 2026 | Fred Hand
Officer
|
Grant | 12.1K | - |
| Mar 19, 2026 | Nicholas David George Jones
Officer
|
Grant | 30.8K | - |
| Mar 19, 2026 | Jennifer J Kent
Officer
|
Grant | 20.8K | - |
| Mar 19, 2026 | Christie Raymond
Officer
|
Grant | 20.8K | - |
| Mar 19, 2026 | Marissa Steinmetz
Officer
|
Grant | 161.5K | - |
| Mar 19, 2026 | Jill Timm
Chief Financial Officer
|
Grant | 32.4K | - |
| Mar 13, 2026 | Jennifer J Kent
Officer
|
Grant | 7.4K | - |
| Dec 24, 2025 | Wendy C Arlin
Director
|
Grant | 183 | - |
| Dec 24, 2025 | Yael Cosset
Director
|
Grant | 164 | - |
| Dec 24, 2025 | H Charles Floyd
Director
|
Grant | 106 | - |
| Dec 24, 2025 | Robbin Mitchell
Director
|
Grant | 143 | - |
| Dec 24, 2025 | Jonas Prising
Director
|
Grant | 124 | - |
| Dec 24, 2025 | John E Schlifske
Director
|
Grant | 252 | - |
| Dec 24, 2025 | Adolfo Villagomez
Director
|
Grant | 106 | - |
| Dec 10, 2025 | Jill Timm
Chief Financial Officer
|
Sell | 10.0K | $240.0K |
| Dec 4, 2025 | Jill Timm
Chief Financial Officer
|
Sell | 25.0K | $568.8K |
| Oct 13, 2025 | Fred Hand
Officer
|
Grant | 9.1K | - |
| Sep 24, 2025 | Wendy C Arlin
Director
|
Grant | 229 | - |
| Sep 24, 2025 | Yael Cosset
Director
|
Grant | 207 | - |
| Sep 24, 2025 | H Charles Floyd
Director
|
Grant | 133 | - |
| Sep 24, 2025 | Robbin Mitchell
Director
|
Grant | 179 | - |
| Sep 24, 2025 | Jonas Prising
Director
|
Grant | 155 | - |
| Sep 24, 2025 | Christie Raymond
Officer
|
Grant | 129 | - |
| Sep 24, 2025 | John E Schlifske
Director
|
Grant | 315 | - |
| Sep 24, 2025 | Adolfo Villagomez
Director
|
Grant | 133 | - |
| Sep 15, 2025 | Steven E. Dee
Chief Technology Officer
|
Grant | 18.7K | - |
| Sep 15, 2025 | Christie Raymond
Officer
|
Grant | 3.7K | - |
| Jul 22, 2025 | Christie Raymond
Officer
|
Sell | 26.5K | $380.0K |
| Jun 25, 2025 | Wendy C Arlin
Director
|
Grant | 476 | - |
| Jun 25, 2025 | Yael Cosset
Director
|
Grant | 430 | - |
| Jun 25, 2025 | H Charles Floyd
Director
|
Grant | 276 | - |
| Jun 25, 2025 | Robbin Mitchell
Director
|
Grant | 372 | - |
| Jun 25, 2025 | Jonas Prising
Director
|
Grant | 323 | - |
| Jun 25, 2025 | Christie Raymond
Officer
|
Grant | 190 | - |
| Jun 25, 2025 | John E Schlifske
Director
|
Grant | 656 | - |
| Jun 25, 2025 | Adolfo Villagomez
Director
|
Grant | 276 | - |
| Jun 13, 2025 | Christie Raymond
Officer
|
Grant | 1.8K | - |
| May 16, 2025 | Michael J Bender
Chief Executive Officer
|
Grant | 441.0K | - |
| May 14, 2025 | Wendy C Arlin
Director
|
Grant | 24.7K | - |
| May 14, 2025 | Yael Cosset
Director
|
Grant | 20.3K | - |
| May 14, 2025 | H Charles Floyd
Director
|
Grant | 17.9K | - |
| May 14, 2025 | Robbin Mitchell
Director
|
Grant | 17.9K | - |
Source: TwelveData, from SEC Form 4 filings
KSS stock forecast: questions people ask
Answered from the figures on this page, as of October 27, 2026.